EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 29 October 2020

19 Conversations | The EFPIA podcast series

Re-imagining Europe’s Future

In the latest podcast from EFPIA, Director General Nathalie Moll asks “not just how we can emerge from the [COVID-19] crisis but can we re-imagine our collective future?”

Part of the 19 conversations podcast series, Nathalie talks about the gap between President von der Leyen’s aspiration "to help ensure Europe has the supply of affordable medicines to meet its needs. In doing so, you should support the European pharmaceutical industry to ensure that it remains an innovator and world leader" and the current policy reality.

Read more

Videos

EFPIA members' efforts against COVID-19: Merck
Merck is playing its part in the fight against COVID-19 Read more

Everything You Always Wanted to Know About Drug Shortages (But were afraid to ask)
We all share the same objective: ensuring that patients get the medicines and vaccines they need in a timely way.... Read more

Events

Orphan Medicines: how to sustain innovation in an area of high unmet need?
30 October 2020 (Virtual event)

For every case where a new treatment has been developed there are however many more rare diseases that still need treatment... Read more

Neuroscience Virtual Partnering
09 November 2020 (Virtual event)

Neurological disorders are one of the most feared diseases in the world – they affect almost a billion people worldwide... Read more

The Economist’s 6th Annual World Cancer Series: Europe
09 November 2020 (Online event)

We will look to the constantly evolving cancer-care landscape across Europe for lessons that can be applied to achieve... Read more

IMI Stakeholder Forum 2020
10 November 2020 (Virtual event)

The theme this year is 'Broader horizons: growing Europe’s health partnership'. Read more

POLITICO's Health Care Summit
17 November 2020 (Virtual event)

Join the many thought-provoking discussions on November 17-18, where you'll be able to debate the biggest EU health... Read more

From silo budgeting to financial integration: Where does the EU stand in diabetes care?
20 November 2020 (Online event)

Lessons learned from an EFPIA/The Economist Intelligence Unit study Read more

Our latest publications

Strengthening Health Systems Through Smart Spending
15 October 2020 (Publications)

EFPIA has developed a number of policy recommendations for national and European policy-makers to inform a discussion... Read more

Position on a European Health Data Space
22 October 2020 (Publications)

EFPIA applauds the European Commission’s (EC) effort to create an EU policy environment that unlocks the value of the... Read more

Alzheimer’s Disease Health System Readiness – The Time to Act is Now
21 September 2020 (Publications)

We are at a turning point in our fight against dementia and Alzheimer’s disease. Long-awaited new therapies are on the... Read more

What we are reading

A Shared Vision for the Future of Health in Europe – Lessons Learnt from the Covid-19 Pandemic...
On 21 October 2020 (EU Health Coalition)

With COVID-19, the need for cooperation between sectors and actors to co-create sustainable solutions has come through... Read more

Big Pharma Was Prepared for COVID-19
On 13 October 2020 (Applied Clinical Trials)

Disa Lee Choun, Head of Innovation at UCB, discusses how they have fostered a culture of innovation, and how the investment... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu